The CGTLive™ Endocrinology specialty topic page houses video interviews with key opinion leaders in the field of endocrinology about the latest relevant FDA actions, clinical guideline updates, and clinical trial findings related to cell therapies, gene therapies, and engineered and regenerative medicines developed for endocrine disorders. It also contains up-to-date clinical news coverage in the field of endocrinology gene and cell therapy.
April 28th 2024
Another recent program in the investigational landscape was Helixmith’s deprioritized Engensis diabetic neuropathy gene therapy.